AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2016 Issue 4; ICD-10-CM NEW/REVISED CODES
Castleman Disease
Subcategory D47.Z, Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue, has been expanded to specifically identify Castleman disease (D47.Z2). Castleman disease describes a group of related lymphoproliferative disorders involving proliferation of morphologically benign lymphocytes due to excessive proinflammatory hypercytokinemia, most notably of interleukin-6. Castleman disease is diagnosed when lymph node histopathology reveals regression of germinal centers, abnormal vascularity, and a range of hyaline vascular changes and/or polytypic plasma cell proliferation. It can occur in a single lymph node region (unicentric) or in multiple lymph node regions (multicentric). Clinical features and management vary significantly...
Subscribe or sign in to view the full article.
Article Overview
This article explains Castleman disease as a lymphoproliferative disorder and discusses how it is recognized within an updated ICD-10-CM classification. It also distinguishes the major clinical forms of the condition and summarizes why the update matters for diagnosis coding, clinical context, and documentation review. The content is aimed at coders, CDI professionals, and clinicians who need a general understanding of the condition and its coding placement.
Why This Topic Matters
Accurate identification of Castleman disease in the code set supports more precise documentation and classification of a condition with differing clinical patterns and management considerations. The article is relevant to professionals who review lymphoid and hematopoietic neoplasm coding in the context of updated ICD-10-CM guidance.
What You Will Learn
- How Castleman disease is categorized clinically and in the ICD-10-CM system
- The general distinction between unicentric and multicentric forms
- Why the condition can present differently across patients and clinical settings
- How an ICD-10-CM expansion can improve specificity in documentation and coding review
Who Should Read This
- Medical coders
- Coding auditors
- Clinical documentation integrity specialists
- Clinicians
- Health information management professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com